NCT03590483

Brief Summary

During the last decades, assisted reproductive technique has been transformed from a miracle to real and has become widely used for treatment human infertility. this was associated with increased the rate of twin pregnancies

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 18, 2018

Completed
Last Updated

July 23, 2018

Status Verified

July 1, 2018

Enrollment Period

1.2 years

First QC Date

June 16, 2018

Last Update Submit

July 20, 2018

Conditions

Keywords

TwinsARTInduction of OvulationPerinatal mortality

Outcome Measures

Primary Outcomes (7)

  • Maternal diabetes using glucose tolerance test

    The diagnosis of GDM was based a fasting plasma glucose level of ≥5.6 mmol/L with 2 h plasma glucose level of ≥7.8 mmol/L

    up to 7 days postpartum

  • Hypertension during pregnancy and preeclampsia diagnosed using ACOG guideline a) weight in kilogram b) Apgar score in first and 10th minutes c)Admission to neonatal intensive acre unit measured in days

    Systolic and diastolic blood pressure equal or more than140/90 mm Hg measured on two or more occasions after 20 weeks of gestation in previously normotensive women, with or without proteinuria (proteinuria of \>100 mg/dL by urine analysis, or \>300 mg/24 h)

    up to 1 week postpartum

  • Maternal anemia using WHO criteria

    Hemoglobin level less than 11gm/dl

    up to 1 week

  • Postpartum hemorrhage

    Bleeding from genital tract of 500 mL or more vaginally

    up to 1 week

  • Neonatal weight in kilogram

    categorized as extreme low birth weight (LBW) for \<1000 g, very LBW for 1000-1500 g, LBW for 1500-2500 g, and normal birth weight for \>2500 g

    up to 7 days

  • Neonatal Apgar(Appearance, Pulse, Grimace, Activity, and Respiration) score

    Apgar scores includes 10 sores , 2 for each . The Apgar score was classified as severely depressed \<0-3\>, moderately depressed\<4-6\> and excellent condition\<7-10\>

    first and fifth minute of life

  • Admission to neonatal care unit in days

    Fetal care unit

    up to 7 days

Secondary Outcomes (1)

  • Maternal mode of delivery

    during labor

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Twin delivery was identified when coming to outpatient clinic \& labour ward into two groups, first group iatrogenic conceived twins (either ART, or medical ovulation induction mainly clomiphene citrate and gonadotrophins).The second group is a twin pregnancy who conceived naturally . Demographic characters, maternal and neonatal outcomes were compared in both groups

You may qualify if:

  • Twin delivered \>24-week gestational age
  • weight ≥ 500g
  • Diachronic diamniotic twins.

You may not qualify if:

  • Intrauterine fetal deaths
  • Higher-order multiple pregnancies
  • Deliveries complicated by early vanishing fetuses
  • Twin pregnancies reduced to singleton
  • Triple pregnancy reduced to twin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kurdistan Board for Medical speciality

Erbil, Kurdistan Region, 44001, Iraq

Location

MeSH Terms

Conditions

Neonatal SepsisPerinatal Death

Condition Hierarchy (Ancestors)

SepsisInfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeath

Study Officials

  • Diana Y. Rashid

    Maternity Teaching Hospital

    PRINCIPAL INVESTIGATOR
  • Shahla K. Alalaf

    Hawler Medical University, College of Medicine

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

June 16, 2018

First Posted

July 18, 2018

Study Start

November 1, 2016

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

July 23, 2018

Record last verified: 2018-07

Locations